Strategies for antiviral therapy in AIDS
- 1 February 1987
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 325 (6107) , 773-778
- https://doi.org/10.1038/325773a0
Abstract
The retrovirus that causes AIDS has revealed enough of its life history for a variety of therapeutic strategies to be apparent. Some of these are suitable for immediate application in clinical trials or have already yielded positive results in some patients.Keywords
This publication has 55 references indexed in Scilit:
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987
- Intra-Blood–Brain-Barrier Synthesis of HTLV-III-Specific IgG in Patients with Neurologic Symptoms Associated with AIDS or AIDS-Related ComplexNew England Journal of Medicine, 1985
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROMEThe Lancet, 1985
- Complete nucleotide sequence of the AIDS virus, HTLV-IIINature, 1985
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- A Pathogenic Retrovirus (HTLV-III) Linked to AIDSNew England Journal of Medicine, 1984
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981
- The Synthesis of 2′,3′-Dideoxyadenosine from 2′-DeoxyadenosineJournal of the American Chemical Society, 1964